drugset / Trial / NCT00490230
Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application
Non-randomizedParallel-groupOpen-label
Summary
Primary Objectives: Assess whether CL (caused by Leishmaniasis major) lesions treated with WR279396 improved the cosmetic outcome compared with no treatment (natural healing)
Timeline
- Start
- 2007-04
- Primary completion
- 2007-06
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gentamicin | Small molecule | — | — |
| Subject | Paromomycin | Small molecule | — | — |